 Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Muthalagu Ramanathan and Jayde Bednarik.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.150 |
|
|
|
-
Wang X, Vogt B, Shanahan L, Siddiqui AD, Subramonia-Iyer S, Khanani S, Bednarik JL, Mittal K, Ramanathan M, Gerber JM, Cerny J. Elotuzumab-based maintenance therapy following autologous stem cell transplant in multiple myeloma deepens post-transplant responses. Blood Cells Mol Dis. 2020 Jul 28; 85:102482.
Score: 0.060
-
Saini N, Cerny J, Furtado V, Desmond A, Zhou Z, Raffel G, Puthawala I, Bednarik J, Shanahan L, Miron P, Woda B, Ramanathan M, Nath R. Elderly do benefit from induction chemotherapy: High dose mitoxantrone based ("5+1") induction chemotherapy regimen in newly diagnosed acute myeloid leukemia. Am J Hematol. 2018 Nov 12.
Score: 0.054
-
Cerny J, Yu H, Ramanathan M, Raffel GD, Walsh WV, Fortier N, Shanahan L, O'Rourke E, Bednarik J, Barton B, Kroll-Desrosiers A, Hao S, Woda B, Hutchinson L, Evens AM, Rosmarin AG, Nath R. Expression of CD25 independently predicts early treatment failure of acute myeloid leukaemia (AML). Br J Haematol. 2013 Jan; 160(2):262-6.
Score: 0.035
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|